SI-BONE, Inc.

NasdaqGM:SIBN Stock Report

Market Cap: US$702.9m

SI-BONE Management

Management criteria checks 4/4

SI-BONE's CEO is Laura Francis, appointed in Apr 2021, has a tenure of 3.83 years. total yearly compensation is $3.71M, comprised of 16.8% salary and 83.2% bonuses, including company stock and options. directly owns 0.84% of the company’s shares, worth $5.93M. The average tenure of the management team and the board of directors is 3.8 years and 14.2 years respectively.

Key information

Laura Francis

Chief executive officer

US$3.7m

Total compensation

CEO salary percentage16.8%
CEO tenure3.8yrs
CEO ownership0.8%
Management average tenure3.8yrs
Board average tenure14.2yrs

Recent management updates

Recent updates

SI-BONE, Inc. (NASDAQ:SIBN) Looks Just Right With A 26% Price Jump

Jan 19
SI-BONE, Inc. (NASDAQ:SIBN) Looks Just Right With A 26% Price Jump

Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues

Nov 04
Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Sep 25
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark

Apr 01
SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark

Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report

Feb 29
Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Feb 28
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Nov 12
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Aug 09
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Is SI-BONE (NASDAQ:SIBN) A Risky Investment?

Apr 20
Is SI-BONE (NASDAQ:SIBN) A Risky Investment?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Jan 01
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Sep 24
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?

Apr 19
SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Jan 05
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Oct 05
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

CEO Compensation Analysis

How has Laura Francis's remuneration changed compared to SI-BONE's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$37m

Jun 30 2024n/an/a

-US$41m

Mar 31 2024n/an/a

-US$43m

Dec 31 2023US$4mUS$622k

-US$43m

Sep 30 2023n/an/a

-US$44m

Jun 30 2023n/an/a

-US$48m

Mar 31 2023n/an/a

-US$55m

Dec 31 2022US$5mUS$604k

-US$61m

Sep 30 2022n/an/a

-US$65m

Jun 30 2022n/an/a

-US$66m

Mar 31 2022n/an/a

-US$62m

Dec 31 2021US$3mUS$527k

-US$57m

Sep 30 2021n/an/a

-US$51m

Jun 30 2021n/an/a

-US$45m

Mar 31 2021n/an/a

-US$43m

Dec 31 2020US$2mUS$386k

-US$44m

Sep 30 2020n/an/a

-US$44m

Jun 30 2020n/an/a

-US$46m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$2mUS$375k

-US$38m

Sep 30 2019n/an/a

-US$35m

Jun 30 2019n/an/a

-US$28m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$734kUS$319k

-US$17m

Compensation vs Market: Laura's total compensation ($USD3.71M) is about average for companies of similar size in the US market ($USD3.20M).

Compensation vs Earnings: Laura's compensation has been consistent with company performance over the past year.

CEO

Laura Francis (57 yo)

3.8yrs

Tenure

US$3,713,871

Compensation

Ms. Laura A. Francis, MBA, serves as Chief Executive Officer and Director at SI-BONE, Inc. since April 18, 2021. She was Chief Financial Officer of SI-Bone Inc. since May 26, 2015 until April 18, 2021 and...

Leadership Team

NamePositionTenureCompensationOwnership
Jeffrey Dunn
Executive Chairman16.8yrsUS$551.18k0.26%
$ 1.8m
Laura Francis
CEO & Director3.8yrsUS$3.71m0.84%
$ 5.9m
Anshul Maheshwari
Chief Financial Officer3.8yrsUS$1.86m0.18%
$ 1.3m
Anthony Recupero
President of Commercial Operations8.6yrsUS$2.06m0.24%
$ 1.7m
Scott Yerby
Senior VP of Engineering & CTOno datano datano data
Saqib Iqbal
Director of FP&A and Investor Relationsno datano datano data
Michael Pisetsky
Chief Business & Legal Affairs Officer8.5yrsno datano data
Aimee Einstein
Vice President of People & Culture3.1yrsno datano data
Daniel Cher
Senior Vice President of Clinical & Regulatory Affairs3.7yrsno datano data
W. Reckling
Chief Medical Officer & VP of Medical Affairsno datano datano data
Nikolas Kerr
Senior Vice President of Product3.8yrsno datano data
Troy Wahlenmaier
Senior Vice President of US Sales1.1yrsno datano data

3.8yrs

Average Tenure

57yo

Average Age

Experienced Management: SIBN's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jeffrey Dunn
Executive Chairman16.8yrsUS$551.18k0.26%
$ 1.8m
Laura Francis
CEO & Director3.8yrsUS$3.71m0.84%
$ 5.9m
Timothy Davis
Lead Independent Director16.8yrsUS$211.30k0.092%
$ 647.0k
Gregory Hinckley
Independent Director14.1yrsUS$191.30k0.38%
$ 2.7m
Jeryl Hilleman
Independent Director5.2yrsUS$206.30k0.025%
$ 175.7k
John Freund
Independent Director12.1yrsUS$188.30k0.31%
$ 2.2m
Ralph Rashbaum
Member of Medical Advisory Board15.1yrsno datano data
Steven Garfin
Member of Medical Advisory Board15.1yrsno datano data
Frank Phillips
Member of Medical Advisory Board15.1yrsno datano data
A. Shamie
Member of Medical Advisory Board14.2yrsno datano data
Mika Nishimura
Independent Director3.9yrsUS$188.30k0.046%
$ 324.3k
Jonathan Hyde
Member of Surgeon Advisory Boardno datano datano data

14.2yrs

Average Tenure

67yo

Average Age

Experienced Board: SIBN's board of directors are seasoned and experienced ( 14.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 01:29
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SI-BONE, Inc. is covered by 15 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Craig BijouBofA Global Research
Caitlin CroninCanaccord Genuity
William PlovanicCanaccord Genuity